Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

phase 1/2 trial

POPULAR ARTICLES

Rocket Pharmaceuticals Announces Data from Phase 1/2 Trial of RP-L102

Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib

ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial

LATEST ARTICLES

NASDAQ:AGLE

Pharmaceutical Investing

Aeglea BioTherapeutics Announces Positive Clinical Update

Pharmaceutical Investing

Atara Will Join Forces with Merck for Clinical Trial

Latest News

Syntheia Provides Telemarketer Services for Political Campaign in British Columbia

Forte Minerals Provides Update on Planned Drill Program at Pucarini High-Sulfidation Gold Project

Bold Ventures Announces Non-Brokered Private Placement and First Tranche Closing

Major Finland Gold Transaction

Halcones Precious Metals Closes Final Tranche of Life Offering and Announces Non-Brokered Offering